Skip to main content
Voyageur Pharmaceuticals Ltd. logo

Voyageur Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · VM ISIN · CA92918C1014 TSXV Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2022-02-24 Regulatory Filings
Country CA Canada
Listing TSXV VM

About Voyageur Pharmaceuticals Ltd.

https://voyageurpharmaceuticals.ca/

Voyageur Pharmaceuticals Ltd. develops and supplies contrast media products for medical imaging, including CT scans and fluoroscopy. The company operates using a vertically integrated "Earth to Bottle" strategy, controlling the entire supply chain from raw mineral acquisition to finished pharmaceutical product. Voyageur owns a significant, high-purity barium sulfate resource, positioning it as a secure and sustainable supplier of pharmaceutical-grade barium sulfate, the active ingredient in its commercialized contrast agents (e.g., SmoothX® and SmoothHD® series). This vertical control aims to ensure supply security and cost competitiveness, primarily targeting the North American market. The company is also actively developing iodine-based contrast media and V-Gas® Effervescent Granules to expand its portfolio of diagnostic imaging solutions.

Recent filings

Filing Released Lang Actions
Other.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'NI 43-101 TECHNICAL REPORT ON THE PRELIMINARY ECONOMIC ASSESSMENT (PEA) FRANCES CREEK PROJECT BRITISH-COLUMBIA, CANADA' and is prepared for Voyageur Pharmaceuticals Ltd. It includes detailed technical and economic assessment information such as property description, geology, drilling, sample preparation, mineral resource estimates, and economic analysis. NI 43-101 reports are technical reports related to mining projects, providing detailed exploration and economic assessment data. This is a comprehensive technical report rather than an announcement or summary. It is not an annual report, earnings release, or any other financial filing type. Therefore, the best fitting category is Regulatory Filings (RNS) as NI 43-101 technical reports are regulatory filings under Canadian securities law but do not fit into other specific financial report categories.
2022-02-24 English
Material change report - English.pdf
Regulatory Filings
2022-02-22 English
Technical report (NI 43-101) - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'NI 43-101 Technical Report Jubilee Mountain Property' and prepared in accordance with National Instrument 43-101, which is a Canadian regulatory standard for disclosure of mineral project information. It includes a Certificate of Qualified Person, detailed geological, exploration, and mineral resource information, and extensive technical data related to a mineral resource estimate. The document is about 15,000 characters long, indicating it is a full technical report rather than a brief announcement. NI 43-101 reports are specialized technical reports for mineral projects and do not fall under typical financial report categories like Annual Report or Interim Report. They are not announcements or certifications but detailed technical disclosures. Given the specificity and nature of the document, it best fits under Regulatory Filings (RNS), which is the fallback category for filings that do not neatly fit into other categories, including technical mineral resource reports like NI 43-101.
2022-02-17 English
News release - English.pdf
Report Publication Announcement Classification · 95% confidence The document is a news release announcing the publication of a NI 43-101 technical report for the Jubilee Mountain copper polymetallic project. It includes details about the report's effective date, the qualified person who authored it, and highlights from the report. The document also discusses the company's staking of additional claims and strategic focus. The NI 43-101 report is a technical report standard for mineral projects in Canada, typically a detailed exploration and resource report. The document is not the full report itself but an announcement of its publication and summary highlights. It does not contain full financial statements or detailed financial analysis. The document length is 5692 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, according to the "Menu vs Meal" rule, this document should be classified as a Report Publication Announcement (RPA) rather than the NI 43-101 report itself or any other financial filing type.
2022-02-16 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'FORM 51-102F3 Material Change Report' and details a material change announcement by Voyageur Pharmaceuticals Ltd. It includes a summary and full description of a Preliminary Economic Assessment (PEA) for a mining project, with detailed economic, resource, capital cost, and sensitivity analysis information. The document is a regulatory filing under Canadian securities law (NI 51-102), specifically a material change report, which is a disclosure document announcing significant corporate developments. It is not a full annual or quarterly financial report, audit report, earnings release, or other financial statement. It is a formal regulatory disclosure of a material event. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories. The document length (15,000 characters) and detailed content confirm it is not a mere announcement of a report (RPA) but a substantive regulatory filing. Confidence is high due to clear identification of the form and content.
2022-01-18 English
News release - English.pdf
Regulatory Filings
2022-01-12 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.